Binimetinib (Mektovi)

Status:: Red
Decision Date:: December 2018

Comments

RED:

Treatment of unresectable or metastatic melanoma with BRAF V600 mutation.

NHS England drug - to be used in line with NHSE commissioning intentions.

Red Drug Classifications

8. NHS England commissioned – to be used in line with NHSE commissioning intentions